产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20316 | Rucaparib Camsylate | 1859053-21-6 | 98% Min. |  |
| Rucaparib camsylate is a potent, orally available inhibitor of poly ADP-ribose polyme | ||||
| 21235 | Rhosin hydrochloride | 1281870-42-5 | 98% Min. |  |
| 20123102 | (R,Z)-1-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino) quinazolin-6-yl)but-2-yn-1-one O-morpholin-3-ylmethyl oxime | 1831116-75-6 | 98% Min. |  |
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. | .png) |
| Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton | ||||
| 2071545 | Remdesivir | 1809249-37-3 | 98% Min. |  |
| Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside anal | ||||
| 2071520 | RK-287107 | 2171386-10-8 | 98% Min. |  |
| RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold select | ||||
| 207101 | RBN-2397 | 2381037-82-5 | 98% Min. |  |
| 2062334 | (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate | 2161337-98-8 | 98% Min. |  |
| 202329 | (R)-methyl 2-(tert-butyldimethylsilyloxy)propanoate | 171230-81-2 | 98% Min. |  |
| 2062017 | 3-[(2RS)-tetrahydro-2H-pyran-2-yloxy]propanoic acid | 1221443-23-7 | 96% Min. |  |
| 2062004 | [(1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate | 1369768-29-5 | ≧95.0% | -2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl)methyl_acetate_1369768-29-5.gif) |
| 690120 | Rigosertib | 592542-59-1 | 98% Min. |  |
| Rigosertib(ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, w | ||||
| 206102 | Resatorvid | 243984-11-4 | 98% Min. |  |
| Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b | ||||
| 204503 | RU320521 | 2262452-06-0 | 98% Min. |  |
| RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in | ||||
| 580586 | (2R)-2-乙炔-2-甲基-1-吡咯烷乙酸 1,1-二甲基乙酯 | 2086689-88-3 | >96% |  |
| (2R)-2-乙炔-2-甲基-1-吡咯烷乙酸 1,1-二甲基乙酯 是 Pamiparib合成中一 | ||||
| 193111 | Remetinostat | 946150-57-8 | >98% |  |
| Remetinostat，也被称为SHP-141，是一种外用制剂，含有组蛋白脱乙酰 | ||||
| 19355 | RG7834 | 2072057-17-9 | >98% |  |
| RG7834,也称为RO7020322,是一种新型口服HBV病毒基因表达抑制剂阻断病 | ||||
| 19353 | RWJ-56110 | 252889-88-6 | >98% |  |
| RWJ-56110是一种选择性蛋白酶活化受体-1 (PAR1)拮抗剂。它阻断凝血酶 | ||||
| 19313 | RBC8 | 361185-42-4 | >98% |  |
| RBC8是一种RalA和RalB GTPase抑制剂(EC50 ~ 3.5μM)。RBC8抑制小鼠异种移植 | ||||
| 192277 | Rogaratinib | 1443530-05-9 | >98% |  |
| Rogaratinib, 也称为BAY-1163877, 是一种异常的成纤维细胞生长因子受体 | ||||
| 192254 | Rebimastat | 259188-38-0 | >98% |  |
| Rebimastat，又名BMS275291，是一种具有潜在抗肿瘤活性的巯基第二代 | ||||
| 192193 | Retosiban | 820957-38-8 | >98% |  |
| Retosiban，又称GSK-221149-A;是一种口服活性强、选择性强的亚纳米(Ki | ||||
| 19183 | RKI-1313 | 1342276-76-9 | >98% |  |
| RKI-1313是RKI-1447 (GLXC-05200)的阴性对照，是Rho-相关ROCK激酶的有效抑 | ||||
| 19181 | RGX-104 free form | 610318-54-2 | >98% |  |
| RGX-104，又称SB 742881，是肝脏X受体激动剂，具有潜在的免疫调节和 | ||||
| 1811151 | R547 | 741713-40-6 | >98% |  |
| R547是口服生物有效的二氨基嘧啶环磷酰胺依赖性激酶抑制剂(CDKI) | ||||
| 1810224 | Regadenoson | 313348-27-5 | >98% |  |
| Regadenoson是一种A2A腺苷受体激动剂，是一种冠状血管舒张剂，通常 | ||||
| 186251 | RMC-4550 | 2172651-73-7 | >98% |  |
| RMC-4550一种有效且具有选择性的SHP2抑制剂。 | ||||
| 186234 | RGX-104盐酸盐 | 610318-03-1 | >98% |  |
| RGX-104是一种具有潜在免疫调节和抗肿瘤活性的肝X受体激动剂。 | ||||